307 related articles for article (PubMed ID: 24815695)
1. Toll like receptor 2 knock-out attenuates carbon tetrachloride (CCl4)-induced liver fibrosis by downregulating MAPK and NF-κB signaling pathways.
Ji L; Xue R; Tang W; Wu W; Hu T; Liu X; Peng X; Gu J; Chen S; Zhang S
FEBS Lett; 2014 Jun; 588(12):2095-100. PubMed ID: 24815695
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of MAPK and NF-κB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice.
Shu M; Huang DD; Hung ZA; Hu XR; Zhang S
Biochem Biophys Res Commun; 2016 Feb; 471(1):233-9. PubMed ID: 26845355
[TBL] [Abstract][Full Text] [Related]
3. Quercetin attenuates the activation of hepatic stellate cells and liver fibrosis in mice through modulation of HMGB1-TLR2/4-NF-κB signaling pathways.
Li X; Jin Q; Yao Q; Xu B; Li Z; Tu C
Toxicol Lett; 2016 Nov; 261():1-12. PubMed ID: 27601294
[TBL] [Abstract][Full Text] [Related]
4. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
[TBL] [Abstract][Full Text] [Related]
5. Quercetin protects mouse liver against CCl₄-induced inflammation by the TLR2/4 and MAPK/NF-κB pathway.
Ma JQ; Li Z; Xie WR; Liu CM; Liu SS
Int Immunopharmacol; 2015 Sep; 28(1):531-9. PubMed ID: 26218279
[TBL] [Abstract][Full Text] [Related]
6. Caffeic acid phenethyl ester attenuates pro-inflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-κB signaling.
Zhao WX; Wang L; Yang JL; Li LZ; Xu WM; Li T
Int J Mol Med; 2014 Mar; 33(3):687-94. PubMed ID: 24378685
[TBL] [Abstract][Full Text] [Related]
7. Toll-Like Receptor 4-Independent Carbon Tetrachloride-Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice: Role of Hepatic Stellate Cells.
Kumar S; Wang J; Shanmukhappa SK; Gandhi CR
Am J Pathol; 2017 Jun; 187(6):1356-1367. PubMed ID: 28412299
[TBL] [Abstract][Full Text] [Related]
8. Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells.
Siegmund SV; Schlosser M; Schildberg FA; Seki E; De Minicis S; Uchinami H; Kuntzen C; Knolle PA; Strassburg CP; Schwabe RF
PLoS One; 2016; 11(3):e0150893. PubMed ID: 26937641
[TBL] [Abstract][Full Text] [Related]
9. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA
Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385
[TBL] [Abstract][Full Text] [Related]
11. Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis.
Nabeshima Y; Tazuma S; Kanno K; Hyogo H; Iwai M; Horiuchi M; Chayama K
Biochem Biophys Res Commun; 2006 Aug; 346(3):658-64. PubMed ID: 16774739
[TBL] [Abstract][Full Text] [Related]
12. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis.
Kao YH; Lin YC; Tsai MS; Sun CK; Yuan SS; Chang CY; Jawan B; Lee PH
Biochim Biophys Acta; 2014 Sep; 1842(9):1720-32. PubMed ID: 24970745
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
15. Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways.
Cao F; Zhang Y; Li W; Shimizu K; Xie H; Zhang C
Int Immunopharmacol; 2018 Feb; 55():183-192. PubMed ID: 29268190
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis.
Huang SS; Chen DZ; Wu H; Chen RC; Du SJ; Dong JJ; Liang G; Xu LM; Wang XD; Yang YP; Yu ZP; Feng WK; Chen YP
Eur J Pharmacol; 2016 May; 779():22-30. PubMed ID: 26945822
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W
Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855
[TBL] [Abstract][Full Text] [Related]
18. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway.
Shi H; Dong L; Jiang J; Zhao J; Zhao G; Dang X; Lu X; Jia M
Toxicology; 2013 Jan; 303():107-14. PubMed ID: 23146752
[TBL] [Abstract][Full Text] [Related]
19. Activation of Slit2-Robo1 signaling promotes liver fibrosis.
Chang J; Lan T; Li C; Ji X; Zheng L; Gou H; Ou Y; Wu T; Qi C; Zhang Q; Li J; Gu Q; Wen D; Cao L; Qiao L; Ding Y; Wang L
J Hepatol; 2015 Dec; 63(6):1413-20. PubMed ID: 26264936
[TBL] [Abstract][Full Text] [Related]
20. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
Downer EJ; Johnston DG; Lynch MA
Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
